National Center for Complementary and Alternative Medicine (NCCAM)

NIH…Turning Discovery Into Health®

Follow NCCAM: Subscribe to our email update Subscribe to the NCCAM RSS feed Follow NCCAM on TwitterRead our disclaimer about external links Follow NCCAM on FacebookRead our disclaimer about external links

Menu

Dr. Jane F. Kinsel Named NCCAM's Associate Director for Science Policy and Operations


For Immediate Release:

Sunday, July 29, 2001

Contact

Anita Greene
NCCAM Press Office, 301-496-1712

Bethesda, MD—Jane F. Kinsel, Ph.D., M.B.A., was appointed associate director for Science Policy and Operations within the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH). In this position, Dr. Kinsel will serve as senior advisor to NCCAM’s director on science, science policy, and other strategic issues, as well as oversee the rigorous planning for and evaluation of the Center’s scientific initiatives and operating programs. In addition, Dr. Kinsel replaces Dr. Richard Nahin in the capacity of executive secretary of the National Advisory Council for Complementary and Alternative Medicine—NCCAM’s advisory counsel.

“This position offers a unique opportunity to design, direct, and implement an innovative and aggressive program to plan the Center’s investments across the many complex areas of science in complementary and alternative medicine (CAM) research, to critically appraise the success of those investments, and to help articulate their results to our many stakeholders,” said Stephen E. Straus, M.D., NCCAM Director. “Dr. Kinsel brings extraordinary scientific, strategic, and managerial expertise to her new position, and I am confident that she will greatly enhance the Center’s capacity to navigate thoughtfully through the many challenges and opportunities of research in CAM,” said Dr. Straus.

Dr. Kinsel began her career at NIH in 1989 as chief of the Pharmaceutical Affairs section of the Pharmaceutical and Regulatory Affairs Branch of the National Institute of Allergy and Infectious Diseases (NIAID). She later became assistant director of NIAID’s Division of Microbiology and Infectious Diseases. In 1998, she advanced to Director of NIAID’s Office of Policy Analysis. Prior to her NIH career, Kinsel was a pharmacologist in the Division of Bioequivalence at the U.S. Food and Drug Administration.

Dr. Kinsel received her bachelor’s degree in chemistry from the University of Delaware, and earned her master’s degree and doctorate in pharmaceutical chemistry from the University of Kansas. She holds a master’s in business administration from the Wharton School.

Throughout her NIH career, Dr. Kinsel has contributed extensively in many areas. While at NIAID, She helped develop a strategic plan for health disparities, as well as a strategic plan for the Institute. Dr. Kinsel has vast experience in science policy development, analysis, evaluation, and reporting functions. At NIAID, she developed and coordinated the Institute’s annual planning cycle and advised various task forces on planning needs of the Institute. She also managed the Institute’s annual scientific planning and reporting process.

A seasoned professional in congressional relations, Dr. Kinsel has broad experience fostering positive and productive congressional relations, and handling recurring and ad hoc requests from Congress, industry, and academia. Other areas of expertise include regulatory affairs and drug development. Among her many achievements, she also is fluent in Russian.

Dr. Kinsel officially assumed her new position on May 20, 2001.